Innovative Treatment RefleXion Medical's recent FDA clearance of the SCINTIX biology-guided radiotherapy system positions it at the forefront of targeted cancer treatments, offering advanced solutions for hospitals and cancer centers seeking cutting-edge therapies.
Strategic Partnerships The company's collaborations with biotechnology firms like 3B Pharmaceuticals and recent licensing agreements expand its treatment portfolio, creating opportunities to integrate radiopharmaceuticals into existing oncology workflows.
Strong Investor Support RefleXion secured a $105 million funding round led by The Rise Fund, indicating strong investor confidence, which can be leveraged to target healthcare providers and institutions interested in innovative cancer treatment modalities.
Market Expansion The launch of the RefleXion X1 device at major industry events demonstrates efforts to accelerate adoption, presenting sales prospects among early adopters and leading oncology centers eager for novel radiotherapy solutions.
Recent Legal Developments Ongoing legal actions, such as the suit filed by Salem Health, highlight competitive and market challenges but also underscore the need for strategic engagement with healthcare providers to establish trust and expand market presence.
RefleXion Medical uses 8 technology products and services including AutoCAD, Salesforce Field Service Lightning, Font Awesome, and more. Explore RefleXion Medical's tech stack below.
| RefleXion Medical Email Formats | Percentage |
| FLast@reflexionmedical.com | 82% |
| First@reflexionmedical.com | 9% |
| First.Last@reflexionmedical.com | 5% |
| FirstLast@reflexionmedical.com | 4% |
| FLast@reflexion.com | 75% |
| Last@reflexion.com | 15% |
| First@reflexion.com | 7% |
| First.Last@reflexion.com | 3% |
Medical Equipment ManufacturingCalifornia, United States51-200 Employees
SCINTIX biology-guided radiotherapy now FDA cleared. SCINTIX® therapy detects and responds to signals emitted from the cancer itself and, for the first time, uses them to deliver immediate treatment for tumors in the lung or bone that may arise from primary or metastatic disease.
Company Overview
Media & News
Funding & FinancialsRefleXion Medical has raised a total of $105M of funding over 11 rounds. Their latest funding round was raised on Nov 15, 2023 in the amount of $105M.
Funding & FinancialsRefleXion Medical has raised a total of $105M of funding over 11 rounds. Their latest funding round was raised on Nov 15, 2023 in the amount of $105M.
1-888-653-2347 
support@leadiq.com